V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212948 | 20079485 | 1.73 | 56 | Palliative (P) | 2018-01-31 | 2018-02-08 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100837095 |
| 20212949 | 20079486 | 1.81 | 41.5 | Palliative (P) | 2005-07-10 | 2019-11-16 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101107480 |
| 20212951 | 20079487 | null | null | Curative (C) | 2019-09-22 | 2019-10-10 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101226696 |
| 20212952 | 20079488 | 1.8 | 72.45 | Palliative (P) | 2018-04-03 | 2018-04-19 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100236594 |
| 20212953 | 20079489 | 0 | 0 | Palliative (P) | 2019-04-21 | 2019-04-24 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101239764 |
| 20212954 | 20079490 | 1.82 | 82 | Palliative (P) | 2019-02-12 | 2019-02-15 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101779451 |
| 20212955 | 20079491 | 1.79 | 78 | Curative (C) | 2019-02-25 | 2019-03-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100907274 |
| 20212956 | 20079492 | 1.62 | 82.3 | Palliative (P) | 2018-11-27 | 2019-01-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101691782 |
| 20212958 | 20079493 | 1.56 | 94.8 | Palliative (P) | 2018-05-22 | 2018-05-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100625462 |
| 20212959 | 20079494 | 1.53 | 67.7 | Neo-adjuvant (N) | 2018-09-02 | 2018-09-16 | Capecitabine + Carboplatin + RT | null | N | CAPECITABINE + CARBOPLATIN | 100352287 |
| 20212960 | 20079495 | null | 54.7 | Palliative (P) | 2017-08-10 | 2017-08-26 | Capecitabine (21days) + Carboplatin | 2 | N | CAPECITABINE + CARBOPLATIN | 101647682 |
| 20212961 | 20079496 | 1.7 | 47 | Palliative (P) | 2016-06-09 | 2016-06-24 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100812627 |
| 20212962 | 20079497 | 1.83 | 80.8 | Curative (C) | 2019-02-07 | 2019-02-21 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100421157 |
| 20212963 | 20079498 | null | null | Curative (C) | 2016-03-21 | 2016-05-20 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101488233 |
| 20212964 | 20079499 | 1.65 | null | Palliative (P) | 2017-06-18 | 2017-07-07 | Capecitabine (14 days)+Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101417165 |
| 20212965 | 20079500 | null | null | null | 2016-11-22 | 2016-11-23 | Capecitabine (21days) + Carboplatin | 02 | null | DOXORUBICIN EMBOLISATION | 100355412 |
| 20212967 | 20079501 | null | null | 03 | 2019-08-14 | 2019-09-11 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101193172 |
| 20212968 | 20079502 | 1.66 | 90.3 | Palliative (P) | 2019-03-30 | 2019-04-09 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 100471017 |
| 20212969 | 20079503 | 0 | 0 | Palliative (P) | null | 2017-09-27 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100197975 |
| 20212971 | 20079504 | 0 | 0 | Palliative (P) | 2017-12-07 | 2017-12-27 | Capecitabine (21days) + Carboplatin | 02 | Y | DOXORUBICIN EMBOLISATION | 100276952 |
| 20212972 | 20079505 | 1.81 | 44 | Palliative (P) | 2019-01-22 | 2019-02-01 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100447439 |
| 20212973 | 20079506 | null | null | Neo-adjuvant (N) | 2019-05-14 | 2019-05-14 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101828419 |
| 20212976 | 20079507 | 1.8 | 76 | 03 | 2017-10-02 | 2017-10-07 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100711760 |
| 20212977 | 20079508 | 1.78 | 82 | Curative (C) | 2018-03-11 | 2018-03-25 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101814292 |
| 20212978 | 20079509 | 1.67 | 86.2 | Curative (C) | 2018-10-06 | 2018-10-20 | CISPLATIN + FLUOROURACIL | 2 | null | CISPLATIN + FLUOROURACIL | 101279787 |
| 20212979 | 20079510 | 1.51 | 79.8 | Neo-adjuvant (N) | 2018-07-06 | 2018-07-11 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100197696 |
| 20212980 | 20079511 | 1.66 | 75.3 | Palliative (P) | 2017-12-12 | 2017-12-12 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101563427 |
| 20212982 | 20079512 | 1.79 | 59.9 | 03 | 2018-05-31 | 2018-05-31 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101235296 |
| 20212983 | 20079513 | 1.77 | 69 | Palliative (P) | 2018-02-15 | 2018-02-24 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101521143 |
| 20212984 | 20079514 | 1.61 | null | null | 2016-11-16 | 2016-12-01 | CISPLATIN + FLUOROURACIL | N | null | CISPLATIN + FLUOROURACIL | 100751816 |
| 20212985 | 20079515 | 0 | 0 | Curative (C) | 2018-01-17 | 2018-02-08 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 101765371 |
| 20212987 | 20079516 | 1.85 | 79.6 | null | 2017-04-04 | 2017-04-04 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100369385 |
| 20212988 | 20079517 | 1.61 | 73.6 | 03 | 2017-11-14 | 2017-11-28 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100217054 |
| 20212989 | 20079518 | 1.61 | 79.79 | null | 2019-03-28 | 2019-04-08 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101370655 |
| 20212990 | 20079519 | 1.81 | 84.4 | Curative (C) | 2019-12-12 | 2019-12-12 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100837165 |
| 20212992 | 20079520 | 1.68 | 75.3 | Curative (C) | 2019-01-19 | 2019-01-26 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101453602 |
| 20212993 | 20079521 | 1.85 | 56 | Palliative (P) | 2019-06-18 | 2019-06-18 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101332520 |
| 20212994 | 20079522 | 1.68 | 69.6 | Neo-adjuvant (N) | null | 2018-09-16 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101532478 |
| 20212995 | 20079523 | 1.59 | 84.6 | null | 2020-05-20 | 2020-05-23 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100296693 |
| 20212996 | 20079524 | 1.6 | 56.5 | null | 2019-02-16 | 2019-03-12 | CISPLATIN + FLUOROURACIL | N | null | CISPLATIN + FLUOROURACIL | 100906126 |
| 20212997 | 20079525 | 1.57 | 78.9 | Palliative (P) | 2016-05-16 | 2016-05-19 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101770048 |
| 20212998 | 20079526 | 1.78 | 75.2 | Neo-adjuvant (N) | 2019-09-02 | 2019-09-04 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100592570 |
| 20212999 | 20079527 | 1.88 | 102.3 | Palliative (P) | 2017-03-04 | 2017-03-18 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101545670 |
| 20213000 | 20079528 | 1.68 | 78.9 | null | 2017-01-11 | 2017-01-11 | Capecitabine + Carboplatin + RT | 02 | null | CAPECITABINE + CARBOPLATIN | 101800398 |
| 20213001 | 20079529 | 1.55 | 80.1 | 03 | 2018-04-25 | 2018-04-27 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101608794 |
| 20213002 | 20079530 | 1.63 | null | Curative (C) | 2017-06-10 | 2017-06-20 | Cisplatin +Fluorouracil (2 wk) | N | N | CISPLATIN + FLUOROURACIL | 100967433 |
| 20213004 | 20079531 | null | 49 | Adjuvant (A) | 2020-08-31 | 2020-08-31 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100124106 |
| 20213005 | 20079532 | 1.75 | 77.2 | Palliative (P) | 2019-09-23 | 2019-09-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100410749 |
| 20213006 | 20079533 | 1.48 | 93.7 | Curative (C) | 2018-12-18 | 2018-12-22 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101588646 |
| 20213008 | 20079534 | 1.7 | 95.4 | Palliative (P) | 2019-04-06 | 2019-04-09 | CISPLATIN + FLUOROURACIL | 2 | N | CISPLATIN + FLUOROURACIL | 101415536 |